Retatrutide is a novel investigational peptide that functions as a triple agonist for GLP-1, GIP, and glucagon receptors. Research focuses on its potential to influence metabolic regulation, energy expenditure, and appetite control. It has been studied in preclinical models for its multi-pathway approach to glucose and weight regulation.
